First National Corp’s iShares Biotechnology ETF IBB Stock Holding History

First National Corp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$383K	Buy	+2,582	New	+$352K	0.07%	126
2024 Q4	–	Sell	-5,818	Closed	-$847K	–	156
2024 Q3	$847K	Sell	5,818 -10,083	-63%	-$1.46M	0.19%	82
2024 Q2	$2.18M	Buy	15,901 +779	+5%	+$104K	0.52%	44
2024 Q1	$2.05M	Sell	15,122 -37	-0.2%	-$5.05K	0.51%	42
2023 Q4	$2.06M	Buy	15,159 +978	+7%	+$119K	0.51%	43
2023 Q3	$1.73M	Buy	14,181 +3,902	+38%	+$496K	0.47%	49
2023 Q2	$1.3M	Buy	10,279 +5,028	+96%	+$653K	0.31%	64
2023 Q1	$678K	Buy	+5,251	New	+$687K	0.16%	89
2019 Q2	–	Sell	-949	Closed	-$106K	–	259
2019 Q1	$106K	Buy	949 +1	+0.1%	+$110	0.04%	174
2018 Q4	$91K	Buy	+948	New	+$101K	0.04%	189

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

First National Corp's IBB Position: Q3 2025 in Review

First National Corp opened a new position in iShares Biotechnology ETF (IBB) in Q3 2025: 2,582 shares worth $383K. The stake represents 0.07% of the portfolio and ranks #126 among its holdings. This is a return to the name: First National Corp previously reported a position in IBB as recently as Q3 2024.

First National Corp first reported a position in IBB in Q4 2018 and has held it in 10 quarters since. The position peaked at $2.18M in Q2 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

First National Corp held 2,582 shares of iShares Biotechnology ETF worth $383K as of Q3 2025.
iShares Biotechnology ETF was a new First National Corp position in Q3 2025.
iShares Biotechnology ETF made up 0.07% of First National Corp's portfolio in Q3 2025, its #126 holding.
First National Corp first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 10 quarters since.
First National Corp's iShares Biotechnology ETF position peaked at $2.18M in Q2 2024.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on First National Corp's 13F filing for Q3 2025, filed 28 Oct 2025.